With Arbor Biotechnologies on-track for year-end IND/CTA filing of their LNP-mediated gene editing therapy and LNPs continuing to be the hottest delivery vehicle across all payload types, completely dominating the non-viral delivery field, the promise of this delivery vehicle is truly exciting!

The 4th LNP Formulation and Process Development Summit returns to Boston, as the only industry summit dedicated to showcasing the hottest pre-clinical and clinical data, overcoming the greatest challenges within the LNP IP space and uncovering the most innovative LNP formulations for cell-specific delivery outside the liver.

Time: 8:00 AM – 5:00 PM

Venue details: The Westin Copley Place, Boston, 10 Huntington Avenue, Boston, Massachusetts, 02116, United States

Prices: USD 2799.00 – USD 5297.00

Speakers: Annette Bak Head, Advanced Drug Delivery, AstraZeneca, Magali Hickey Head, LNP Process Development, Moderna, Pieter Cullis Professor, University of British Columbia, Sanyogitta Puri Senior Director, Non- Viral Delivery, Novo Nordisk, and more